ChromaDex Shares Jump on Tru Niagen's Launch In Walmart Stores


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


  • ChromaDex Corp (NASDAQ:CDXChas launched its flagship consumer product Tru Niagen in Walmart Inc (NYSE:WMT), available in 3,800 stores across the U.S.
  • The NAD+ booster will be offered to Walmart customers in two distinct serving sizes, 100mg and 300mg.
  • Tru Niagen is a form of vitamin B3 clinically proven to elevate NAD+, reducing the impact of aging and daily wear and tear on the body.
  • NAD+ is a vital coenzyme naturally produced in the body, and studies have shown NAD+ declines up to 50% between the ages of 40 and 60.
  • Based on a 300mg/day serving, Tru Niagen can increase NAD+ by 40-50%.
  • Related content: ChromaDex CEO Rings Nasdaq Closing Bell, Talks Walmart Product Launch.
  • Price Action: CDXC shares are up 11.7% at $9.99 during the market session on the last check Monday.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsHealth CareContractsSmall CapGeneralBriefs